Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1982 Oct 9;285(6347):998–999. doi: 10.1136/bmj.285.6347.998

High dose of antacid (Mylanta II) reduces bioavailability of ranitidine.

G W Mihaly, A T Marino, L K Webster, D B Jones, W J Louis, R A Smallwood
PMCID: PMC1500341  PMID: 6289961

Abstract

To investigate the effect of antacid on the bioavailability and disposition of ranitidine six healthy volunteers were studied on two occasions one week apart. In the first study the received ranitidine 150 mg with 60 ml water, and in the second study they received ranitidine 150 mg plus 30 ml of an aluminium/magnesium hydroxide mixture (Mylanta II) and 30 ml water. Giving antacid reduced both the maximum plasma ranitidine concentration and the area under the curve by one-third; elimination of the drug was not changed. Thus giving a high dose of antacid significantly diminished the bioavailability of ranitidine.

Full text

PDF
998

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burland W. L., Darkin D. W., Mills M. W. Effect of antacids on absorption of cimetidine. Lancet. 1976 Oct 30;2(7992):965–965. doi: 10.1016/s0140-6736(76)90933-8. [DOI] [PubMed] [Google Scholar]
  2. Gugler R., Brand M., Somogyi A. Impaired cimetidine absorption due to antacids and metoclopramide. Eur J Clin Pharmacol. 1981;20(3):225–228. doi: 10.1007/BF00544602. [DOI] [PubMed] [Google Scholar]
  3. Mihaly G. W., Drummer O. H., Marshall A., Smallwood R. A., Louis W. J. High-pressure liquid chromatographic determination of ranitidine, a new H2-receptor antagonist, in plasma and urine. J Pharm Sci. 1980 Oct;69(10):1155–1157. doi: 10.1002/jps.2600691008. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES